This is a Safety and Tolerability Study Evaluating a New Treatment for Subjects With Mild to Moderate Alzheimer's Disease
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Laura Gault, MD
AbbVie
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
29 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Site Reference Id/investigator# 73514
Poznan, Poland
- Site Reference Id/investigator# 73515
Szczecin, Poland
- Site Reference Id/investigator# 73516
Kazan', Russia
- Site Reference Id/investigator# 73525
Kazan', Russia
- Site Reference Id/investigator# 73523
Kirov, Russia
- Site Reference Id/investigator# 73519
Moscow, Russia
- Site Reference Id/investigator# 73521
Moscow, Russia
- Site Reference Id/investigator# 73517
Novosibirsk, Russia
- Site Reference Id/investigator# 73518
Saint Petersburg, Russia
- Site Reference Id/investigator# 73522
Saint Petersburg, Russia
- Site Reference Id/investigator# 73524
Saint Petersburg, Russia
- Site Reference Id/investigator# 84615
Saint Petersburg, Russia
- Site Reference Id/investigator# 73520
Saratov, Russia
- Site Reference Id/investigator# 73507
Belville, South Africa
- Site Reference Id/investigator# 84614
Cape Town, South Africa
- Site Reference Id/investigator# 73505
George, South Africa
- Site Reference Id/investigator# 73506
Johannesburg, South Africa
- Site Reference Id/investigator# 73533
Donetsk, Ukraine
- Site Reference Id/investigator# 73534
Kiev, Ukraine
- Site Reference Id/investigator# 73535
Poltava, Ukraine
- Site Reference Id/investigator# 73502
Bath, United Kingdom
- Site Reference Id/investigator# 73503
Blackburn, United Kingdom
- Site Reference Id/investigator# 73501
Glasgow, United Kingdom
- Site Reference Id/investigator# 73504
London, United Kingdom
- Site Reference Id/investigator# 73493
Delray Beach, Florida, United States
- Site Reference Id/investigator# 73496
West Palm Beach, Florida, United States
- Site Reference Id/investigator# 73495
Elk Grove Village, Illinois, United States
- Site Reference Id/investigator# 73494
Staten Island, New York, United States
- Site Reference Id/investigator# 97035
Wichita Falls, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Aug 2012
- Primary completion
- 31 Mar 2014
- Completion
- 31 Mar 2014
- Last update posted
- 2 Aug 2021
- Registered enrollment
- 349
- Registry id
- NCT01676935
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.